• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TRI-LOBE BALLOON CATHETER (MODIFIED); CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TRI-LOBE BALLOON CATHETER (MODIFIED); CATHETER, PERCUTANEOUS Back to Search Results
Catalog Number BCM1634J
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Aortic Dissection (2491)
Event Date 07/10/2018
Event Type  Injury  
Manufacturer Narrative
Results pending completion of manufacturing evaluation.
 
Event Description
On (b)(6) 2018, the patient was implanted with two conformable gore® tag® thoracic endoprostheses to treat a thoracic aortic aneurysm.After both endoprostheses were placed, post-implant ballooning was performed using a gore® tri-lobe balloon catheter (bcm1634j/17594551).A procedural angiograph reportedly revealed a dissection at the proximal end of the most proximal gore® tag® device.According to the report, ballooning of the proximal device likely contributed the dissection, which extended to the left subclavian artery.The physician stated that he expected the patient¿s blood vessel would be ¿weak¿.The patient¿s blood pressure was reportedly stable, and procedural angiography did not show any interruption of blood flow to the arch branch vessels.The physician expects the dissection will be thrombosed, and he will continue to monitor the patient.The procedure was completed without any further reported complications, and the patient tolerated the procedure.
 
Manufacturer Narrative
Code 213 ¿ a review of the manufacturing records for the device verified that the lot met all pre-release specifications.Code 22 ¿ per the gore® tri-lobe balloon catheter instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to trauma to the vessel wall, including spasm, dissection, perforation, or rupture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TRI-LOBE BALLOON CATHETER (MODIFIED)
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7770480
MDR Text Key116697528
Report Number3007284313-2018-00221
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
PMA/PMN Number
K081799
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/26/2020
Device Catalogue NumberBCM1634J
Device Lot Number17594551
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age69 YR
-
-